New York State Common Retirement Fund Has $9.12 Million Holdings in Teleflex Incorporated (NYSE:TFX)

New York State Common Retirement Fund decreased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 11.1% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 36,587 shares of the medical technology company’s stock after selling 4,586 shares during the quarter. New York State Common Retirement Fund owned approximately 0.08% of Teleflex worth $9,123,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the business. Rafferty Asset Management LLC boosted its stake in shares of Teleflex by 6.8% during the 3rd quarter. Rafferty Asset Management LLC now owns 4,910 shares of the medical technology company’s stock worth $964,000 after buying an additional 314 shares during the last quarter. Allspring Global Investments Holdings LLC grew its stake in Teleflex by 243.6% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 22,722 shares of the medical technology company’s stock valued at $5,666,000 after purchasing an additional 16,110 shares in the last quarter. Royal London Asset Management Ltd. increased its position in shares of Teleflex by 4.3% during the 3rd quarter. Royal London Asset Management Ltd. now owns 17,753 shares of the medical technology company’s stock worth $3,487,000 after purchasing an additional 737 shares during the last quarter. Raymond James & Associates raised its stake in shares of Teleflex by 10.5% during the 4th quarter. Raymond James & Associates now owns 126,227 shares of the medical technology company’s stock worth $31,473,000 after purchasing an additional 11,943 shares in the last quarter. Finally, Nordea Investment Management AB raised its stake in shares of Teleflex by 8.8% during the 4th quarter. Nordea Investment Management AB now owns 2,964 shares of the medical technology company’s stock worth $738,000 after purchasing an additional 239 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Insiders Place Their Bets

In other news, VP Cameron P. Hicks sold 7,401 shares of the company’s stock in a transaction on Tuesday, March 5th. The stock was sold at an average price of $225.00, for a total transaction of $1,665,225.00. Following the completion of the sale, the vice president now directly owns 10,050 shares in the company, valued at approximately $2,261,250. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Corporate insiders own 1.43% of the company’s stock.

Teleflex Stock Performance

Shares of NYSE TFX opened at $211.60 on Thursday. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.32 and a quick ratio of 1.29. The firm has a market cap of $9.97 billion, a price-to-earnings ratio of 28.10, a P/E/G ratio of 2.00 and a beta of 1.11. The stock’s fifty day moving average price is $218.74 and its two-hundred day moving average price is $226.21. Teleflex Incorporated has a one year low of $177.63 and a one year high of $276.43.

Teleflex (NYSE:TFX) last released its quarterly earnings results on Thursday, February 22nd. The medical technology company reported $3.38 EPS for the quarter, beating the consensus estimate of $3.26 by $0.12. The business had revenue of $773.90 million for the quarter, compared to the consensus estimate of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. Teleflex’s revenue was up 2.1% compared to the same quarter last year. During the same period in the prior year, the company posted $3.52 earnings per share. On average, equities analysts forecast that Teleflex Incorporated will post 13.73 EPS for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, March 15th. Investors of record on Friday, March 1st were given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date was Thursday, February 29th. Teleflex’s dividend payout ratio is currently 18.06%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on TFX. Truist Financial lowered their target price on shares of Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a report on Friday, February 23rd. Royal Bank of Canada cut their target price on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating for the company in a research note on Friday, February 23rd. JMP Securities reissued a “market outperform” rating and set a $285.00 price target on shares of Teleflex in a research report on Friday, February 23rd. Finally, StockNews.com cut Teleflex from a “buy” rating to a “hold” rating in a research report on Friday, February 23rd. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $267.50.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.